Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams(NYU Langone Health), Sunil Badve(Emory University)
Cited by 1,332
Related Papers
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
|JNCI Journal of the National Cancer Institute|2016|521
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells
|Oncogene|2005|305
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
|Clinical Cancer Research|2012|225
Atypical ductal hyperplasia: interobserver and intraobserver variability
|Modern Pathology|2011|121